Wei Pan
About Wei Pan
Wei Pan is the Director of US Hematology, Forecasting and Performance at Bristol Myers Squibb, with extensive experience in business insights and analytics across multiple pharmaceutical companies.
Title
Wei Pan holds the position of Director, US Hematology, Forecasting and Performance at Bristol Myers Squibb.
Company
Wei Pan is currently employed at Bristol Myers Squibb, working in the United States.
Education and Expertise
Wei Pan earned a Master of Arts in Economics from the University at Buffalo in 2010. He also holds a Bachelor of Arts in English and Business from Dalian University of Foreign Languages, obtained in 2007. He possesses strong skills in SAS, Excel, PowerPoint, Qlikview, and Tableau, with deep knowledge of various data sources, including IMS Xponent, Plantrak, DDD, NPA, NSP data, specialty pharmacy data, HUB data, and patient-level claims data.
Career Background
Before his current role at Bristol Myers Squibb, Wei Pan served as Sr. Manager, Business Planning and Insights at Ferring Pharmaceuticals for 9 months in 2019-2020. From 2017 to 2019, he worked as Sr. Manager Business Insights & Analytics at Mallinckrodt Pharmaceuticals. Prior to that, he was a Business Insights and Analytics Consultant at Novartis/KMK for 6 years starting in 2011.
Professional Experience
Wei Pan functions as an internal consultant for commercial teams, integrating analytics with business inquiries and aligning brand strategies with analytic insights. He has collaborated with diverse cross-functional teams, including Marketing, Market Access, Finance, HEOR, Medical, and Patient Service & Reimbursement teams. His role entails effective communication of results, recommendations, and implications to senior management.